Activation of osmo-sensitive LRRC8 anion channels in macrophages is important for micro-crystallin joint inflammation

Calcium pyrophosphate deposition disease

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort

Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP)

Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

Butterfly vertebra

Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome

Constriction ring syndrome: Severe cuts

Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study

2019 EULAR points to consider for the assessment of competences in rheumatology specialty training

Galectin 3 Deficiency Alters Chondrocyte Primary Cilium Formation and Exacerbates Cartilage Destruction via Mitochondrial Apoptosis

Adrenomedullin and truncated peptide adrenomedullin(22-52) affect chondrocyte response to apoptotis in vitro: downregulation of FAS protects chondrocyte from cell death

Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?

Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?

BCP crystals promote chondrocyte hypertrophic differentiation in OA cartilage by sequestering Wnt3a

COVID-19 as a STING disorder with delayed over-secretion of interferon-beta

Spondyloarthritis-Associated IgA Nephropathy

Benefits of Polymerase Chain Reaction Combined With Culture for the Diagnosis of Bone and Joint Infections: A Prospective Test Performance Study

Time-course of tophus resolution on Dual-energy CT and ultrasound after 24months of a treat-to-target strategy: Results from GOUT-DECTUS study

The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout

Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker

Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout

A genome-wide association analysis reveals new pathogenic pathways in gout

Mechanisms and rationale for uricase use in patients with gout

Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout

Simple Application and Adherence to Gout Guidelines Enables Disease Control: An Observational Study in French Referral Centres

Distribution of bony erosions in feet and performance of two bone erosion scores: A dual-energy computed tomography study of 61 patients with gout

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout

UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis

Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages

2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares

2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy

Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

Methotrexate osteopathy in rheumatoid arthritis

Methotrexate also improves rheumatoid arthritis through correction of microbiota dysbiosis

Busting the myth of methotrexate chronic hepatotoxicity

Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study

Adsorption of Proteins on m-CPPD and Urate Crystals Inhibits Crystal-induced Cell Responses: Study on Albumin-crystal Interaction

Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence

Tissue microbiota: A 'secondary-self', first target of autoimmunity?

A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA)

Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study